A Long-Term Follow-up Study of the Severe Parkinson's Disease Patients Administered the IPS101A Gene Therapy Product.
Clinical trial NCT07629115 · RECRUITING
Trial details
- NCT number
- NCT07629115
- Sponsor
- Innopeutics Corporation
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-05-29
- Primary completion
- 2031-07-30
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.